NCT05222854View on ClinicalTrials.gov

"Comprehensive Genomic Profiling Combined With Real Life Data of The German-Registry of Incidental Gallbladder Carcinoma"

Active, not recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2099

Conditions

Gallbladder Carcinoma

Trial Locations (1)

60488

Frankfurter Institut für Klinische Krebsforschung IKF GmbH, Frankfurt am Main

All Listed Sponsors

lead

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

OTHER

NCT05222854 - "Comprehensive Genomic Profiling Combined With Real Life Data of The German-Registry of Incidental Gallbladder Carcinoma" | Biotech Hunter | Biotech Hunter